Evidence map›Paper›PMID 34007963›Full record

ArticleKidney medicine

Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion.

Bruce M Robinson, Murilo Guedes, Mohammed Alghonaim, Aleix Cases, Indranil Dasgupta, Liangying Gan, Stefan H Jacobson, Talerngsak Kanjanabuch, Yong-Lim Kim, Werner Kleophas and 9 more

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. COVID-19 vaccination in peritoneal dialysis patients.International urology and nephrology · 2023
    Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 17 institutions in 15 countries.

Bruce M RobinsonArbor Research Collaborative for Health, Ann Arbor, MI.
Murilo GuedesSchool of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil.
Mohammed AlghonaimSaudi Center for Organ Transplantation, Riyadh, Saudi Arabia.
Aleix CasesUniversity of Barcelona, IDIBAPS, Barcelona, Spain.
Indranil DasguptaRenal Medicine, University Hospitals Birmingham, Birmingham, UK.
Liangying GanDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Stefan H JacobsonDivision of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.
Talerngsak KanjanabuchDivision of Nephrology and Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Thailand.
Yong-Lim KimSchool of Medicine, Kyungpook National University, Daegu, South Korea.
Werner KleophasDavita Germany, Hamburg, Düsseldorf, Germany.
Laura LabriolaDepartment of Nephrology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Rachel L PerlmanUniversity of Michigan, Ann Arbor, MI.
Gianpaolo ReboldiDepartment of Medicine, University of Perugia, Perugia, Italy.
Vesh SrivatanaDivision of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY.
Rita S SuriDivision of Nephrology, McGill University, Montreal, Canada.
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
Pablo Urena TorresAURA Nord Saint Ouen, Saint Ouen, France and Department of Renal Physiology. Necker Hospital, University of Paris Descartes, Paris, France.
Ronald L PisoniArbor Research Collaborative for Health, Ann Arbor, MI.
Roberto Pecoits-FilhoArbor Research Collaborative for Health, Ann Arbor, MI.
Arbor Research Collaborative for Health · USChulalongkorn University · THConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHeinrich Heine University Düsseldorf · DEKarolinska Institutet · SEKyungpook National University · KRMcGill University · CANara Medical University · JPNIHR Surgical Reconstruction and Microbiology Research Centre · GBPeking University People's Hospital · CNPontifícia Universidade Católica do Paraná · BRSaudi Center for Organ Transplantation · SAUCLouvain · BEUniversité Paris Cité · FRUniversity of Michigan–Ann Arbor · USUniversity of Perugia · ITWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the worst global pandemic of the past century, coronavirus disease 2019 (COVID-19) has had a disproportionate effect on maintenance dialysis patients and their health care providers. At a virtual roundtable on June 12, 2020, Dialysis Outcomes and Practice Patterns Study (DOPPS) investigators from 15 countries in Asia, Europe, and the Americas described and compared the effects of COVID-19 on dialysis care, with recent updates added. Most striking is the huge difference in risk to dialysis patients and staff across the world. Per-population cases and deaths among dialysis patients vary more than 100-fold across participating countries, mirroring burden in the general population. International data indicate that the case-fatality ratio remains at 10% to 30% among dialysis patients, confirming the gravity of infection, and that cases are much more common among in-center than home dialysis patients. This latter finding merits urgent study because in-center patients often have greater community exposure, and in-center transmission may be uncommon under optimal protocols. Greater telemedicine use is a welcome change here to stay, and our community needs to improve emergency planning and protect dialysis staff from the next pandemic. Finally, the pandemic's challenges have prompted widespread partnering and innovation in kidney care and research that must be sustained after this global health crisis.

Indexed as

COVID-19dialysisDOPPSinternationalrisk

Identifiers

PMID34007963
PMCPMC8120787
OpenAlexW3163392917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.